Three-Dimensional Physical Model in Urologic Cancer.
Yu Xie1,2, Guanlin Wu3, Yu Liang1
1Department of Urology, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University and the Clinical Research Center for Renal Tumor in Hunan Province, Changsha, China.
Frontiers in Surgery
|June 13, 2022
Summary
Three-dimensional (3D) printing creates precise, patient-specific models for urologic cancer care. This review explores 3D printing applications, benefits, and challenges in urologic oncology, guiding future research.
Area of Science:
- Urologic Oncology
- Medical Technology
- 3D Printing Applications
Background:
- Three-dimensional (3D) printing technology allows for high-precision, patient-specific physical models.
- Its application is rapidly expanding in clinical practices, particularly within urologic cancer care.
- A comprehensive understanding of its role, benefits, and challenges in urologic oncology is increasingly necessary.
Purpose of the Study:
- To review recent studies on 3D printing in urologic cancer.
- To identify and clarify the diverse applications of 3D-printed models.
- To evaluate the benefits and challenges of integrating 3D printing into clinical practice.
Main Methods:
- Mini-review of recently published literature.
- Focus on studies detailing applications, feasibility, simulated organs, outcomes, and challenges.
- Synthesis of current research on 3D printing in urologic cancer.
Main Results:
- 3D-printed models are utilized for patient and trainee education, surgical simulation, and pre-operative planning/guidance.
- Studies demonstrate the feasibility of procedures using these models.
- The review highlights various application outcomes and inherent challenges in urologic cancer treatment.
Conclusions:
- Three-dimensional printing offers significant potential in urologic cancer management.
- Further research is needed to optimize its use and address existing challenges.
- This technology can enhance surgical precision, training, and patient outcomes in urologic oncology.


